Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology

Holm H. Uhlig; Brent S. McKenzie; Sophie Hue; Claire Thompson; Barbara Joyce-Shaikh; Renata Štepánková; Nicolas Robinson; Sofia Buonocore; Helena Tlaskalova-Hogenova; Daniel J. Cua; Fiona Powrie

doi:10.1016/j.immuni.2006.05.017

journal article Open Access Aug 01, 2006

Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology

Holm H. Uhlig

Brent S. McKenzie Sophie Hue Claire Thompson

Barbara Joyce-Shaikh Renata Štepánková Nicolas Robinson Sofia Buonocore Helena Tlaskalova-Hogenova Daniel J. Cua Fiona Powrie

Immunity Vol. 25 No. 2 pp. 309-318 · Elsevier BV

View at Publisher Save 10.1016/j.immuni.2006.05.017

Topics

No keywords indexed for this article. Browse by subject →

References

41

[1]

Becker "Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells" J. Clin. Invest. (2003) 10.1172/jci200317464

[2]

Bouma "The immunological and genetic basis of inflammatory bowel disease" Nat. Rev. Immunol. (2003) 10.1038/nri1132

[3]

Cong "Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12" J. Immunol. (2000) 10.4049/jimmunol.165.4.2173

[4]

Cua "Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain" Nature (2003) 10.1038/nature01355

[5]

De Jong "Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration" Gastroenterology (2000) 10.1053/gast.2000.16485

[6]

Diehl "The role of CD40 in peripheral T cell tolerance and immunity" J. Mol. Med. (2000) 10.1007/s001090000126

[7]

NOD2 and Crohn’s Disease: Loss or Gain of Function?

Lars Eckmann, Michael Karin

Immunity 2005 10.1016/j.immuni.2005.06.004

[8]

Ferlin "CD40 signaling induces interleukin-4-independent IgE switching in vivo" Eur. J. Immunol. (1996) 10.1002/eji.1830261216

[9]

Fuss "Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice" Gastroenterology (1999) 10.1016/s0016-5085(99)70392-6

[10]

Harrington "Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages" Nat. Immunol. (2005) 10.1038/ni1254

[11]

Hunter "New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions" Nat. Rev. Immunol. (2005) 10.1038/nri1648

[12]

Isler "Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10" Am. J. Respir. Cell Mol. Biol. (1999) 10.1165/ajrcmb.20.2.3313

[13]

Kelsall "Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses" Ann. N Y Acad. Sci. (1996) 10.1111/j.1749-6632.1996.tb52660.x

[14]

Krajina "Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis" Eur. J. Immunol. (2003) 10.1002/eji.200323518

[15]

Langrish "IL-12 and IL-23: master regulators of innate and adaptive immunity" Immunol. Rev. (2004) 10.1111/j.0105-2896.2004.00214.x

[16]

Langrish "IL-23 drives a pathogenic T cell population that induces autoimmune inflammation" J. Exp. Med. (2005) 10.1084/jem.20041257

[17]

Liu "Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production" J. Immunol. (1999) 10.4049/jimmunol.163.7.4049

[18]

Liu "Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions" J. Immunol. (2000) 10.4049/jimmunol.164.11.6005

[19]

Ma "TNF-alpha and IL-12: a balancing act in macrophage functioning" Microbes Infect. (2001) 10.1016/s1286-4579(00)01359-9

[20]

Malmstrom "CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice" J. Immunol. (2001) 10.4049/jimmunol.166.11.6972

[21]

Mannon "Anti-interleukin-12 antibody for active Crohn's disease" N. Engl. J. Med. (2004) 10.1056/nejmoa033402

[22]

Mason "Cutting edge: identification of c-Rel-dependent and -independent pathways of IL-12 production during infectious and inflammatory stimuli" J. Immunol. (2002) 10.4049/jimmunol.168.6.2590

[23]

McKenzie "Understanding the IL-23-IL-17 immune pathway" Trends Immunol. (2005) 10.1016/j.it.2005.10.003

[24]

Morelli "Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation" Blood (2001) 10.1182/blood.v98.5.1512

[25]

Murphy "Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation" J. Exp. Med. (2003) 10.1084/jem.20030896

[26]

Neurath "Antibodies to interleukin 12 abrogate established experimental colitis in mice" J. Exp. Med. (1995) 10.1084/jem.182.5.1281

[27]

Neurath "Effect of IL-12 and antibodies to IL-12 on established granulomatous colitis in mice" Ann. N Y Acad. Sci. (1996) 10.1111/j.1749-6632.1996.tb52695.x

[28]

Oppmann "Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12" Immunity (2000) 10.1016/s1074-7613(00)00070-4

[29]

Parham "A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R" J. Immunol. (2002) 10.4049/jimmunol.168.11.5699

[30]

Park "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17" Nat. Immunol. (2005) 10.1038/ni1261

[31]

Polese "The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation" Eur. J. Gastroenterol. Hepatol. (2002) 10.1097/00042737-200203000-00006

[32]

Powrie "Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells" Immunity (1994) 10.1016/1074-7613(94)90045-0

[33]

Rolink "The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching" Immunity (1996) 10.1016/s1074-7613(00)80258-7

[34]

Sandborn "Biologics in inflammatory bowel disease: how much progress have we made?" Gut (2004) 10.1136/gut.2003.025452

[35]

Schmidt "Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease" Pathobiology (2002) 10.1159/000068151

[36]

Shanahan "Crohn's disease" Lancet (2002) 10.1016/s0140-6736(02)07284-7

[37]

Simpson "T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells" J. Exp. Med. (1998) 10.1084/jem.187.8.1225

[38]

Strober "The immunology of mucosal models of inflammation" Annu. Rev. Immunol. (2002) 10.1146/annurev.immunol.20.100301.064816

[39]

Stuber "Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion" J. Exp. Med. (1996) 10.1084/jem.183.2.693

[40]

Trinchieri "The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses" Immunity (2003) 10.1016/s1074-7613(03)00296-6

[41]

van Kooten "CD40-CD40 ligand" J. Leukoc. Biol. (2000) 10.1002/jlb.67.1.2

Cited By

575

CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation

Anees Ahmed, Ann M. Joseph · 2024

Nature

Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut

Mousumi Mahapatro, Lena Erkert · 2021

Cells

Ulcerative colitis

Taku Kobayashi, Britta Siegmund · 2020

Nature Reviews Disease Primers

Epithelial RABGEF1 deficiency promotes intestinal inflammation by dysregulating intrinsic MYD88-dependent innate signaling

Sophie El Abbas, Coraline Radermecker · 2020

Mucosal Immunology

Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain

James R. Burke, Lihong Cheng · 2019

Science Translational Medicine

Identification of N-Methyl Nicotinamide and N-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2)

Ryan Moslin, Yanlei Zhang · 2019

Journal of Medicinal Chemistry

ILC3 function as a double-edged sword in inflammatory bowel diseases

Boning Zeng, Shengnan Shi · 2019

Cell Death & Disease

Intestinal IFN-γ–producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease

Johanna Sophie Alfen, Paola Larghi · 2018

Journal of Allergy and Clinical Imm...

IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting

Alexander R. Moschen, Herbert Tilg · 2018

Nature Reviews Gastroenterology &am...

Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies

Duk Hwan Kim, Jae Hee Cheon · 2017

Immune Network

Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation

Christina Song, Jacob S. Lee · 2015

Journal of Experimental Medicine

Interleukin-23 Promotes Interferon-α Responsiveness in Hepatitis C Virus/HIV-Coinfected Patients

Madeline Odigie, Anu Osinusi · 2014

AIDS Research and Human Retroviruse...

Intestinal CD103− dendritic cells migrate in lymph and prime effector T cells

V Cerovic, S A Houston · 2013

Mucosal Immunology

The Th17 Pathway and Inflammatory Diseases of the Intestines, Lungs, and Skin

Casey T. Weaver, Charles O. Elson · 2013

Annual Review of Pathology: Mechani...

IL‐23: One cytokine in control of autoimmunity

Andrew L. Croxford, Florian Mair · 2012

European Journal of Immunology

Mucosal T cells in gut homeostasis and inflammation

Femke van Wijk, Hilde Cheroutre · 2010

Expert Review of Clinical Immunolog...

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology

Sofia Buonocore, Philip P. Ahern · 2010

Nature

γδ T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent Mechanism

Franziska Petermann, Veit Rothhammer · 2010

Immunity

Th17 Cell Differentiation: The Long and Winding Road

Mandy J. McGeachy, Daniel J. Cua · 2008

Immunity

The IL23 axis plays a key role in the pathogenesis of IBD: Figure 1

Dermot McGovern, Fiona Powrie · 2007

Gut

Metrics

575

Citations

41

References

Details

Published: Aug 01, 2006
Vol/Issue: 25(2)
Pages: 309-318
License: View

Authors

Helena Tlaskalova-Hogenova

D

Daniel J. Cua

Janssen Research and Development, Spring House, PA, USA.

F

Fiona Powrie

Translational Gastroenterology Unit, Experimental Medicine Division, Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX39DU, UK.

Funding

Wellcome Trust

Deutsche Forschungsgemeinschaft Award: H.H.U. 128-2

European Commission Award: EU-IMDEMI MRTN-CT2004-05632

Akademie ved Ceské Republiky Award: A5020205

Cite This Article

Holm H. Uhlig, Brent S. McKenzie, Sophie Hue, et al. (2006). Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology. Immunity, 25(2), 309-318. https://doi.org/10.1016/j.immuni.2006.05.017

Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology

You May Also Like